HEADER HYDROLASE/ANTIBIOTIC 25-APR-12 4EV4 TITLE CRYSTAL STRUCTURE OF SERRATIA FONTICOLA CARBAPENEMASE SFC-1 E166A TITLE 2 MUTANT WITH THE ACYLENZYME INTERMEDIATE OF MEROPENEM COMPND MOL_ID: 1; COMPND 2 MOLECULE: CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 27-309; COMPND 5 EC: 3.5.2.6; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SERRATIA FONTICOLA; SOURCE 3 ORGANISM_TAXID: 47917; SOURCE 4 STRAIN: UTAD54; SOURCE 5 GENE: BLASFC-1, SFC-1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET26-B KEYWDS CARBAPENEMASE, HYDROLASE, ANTIBIOTIC RESISTANCE, BETA-LACTAMASE KEYWDS 2 COMPLEX, HYDROLASE-ANTIBIOTIC COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR F.FONSECA,J.SPENCER REVDAT 3 13-SEP-23 4EV4 1 COMPND REMARK SEQADV HETNAM REVDAT 3 2 1 LINK REVDAT 2 28-AUG-13 4EV4 1 JRNL REVDAT 1 23-MAY-12 4EV4 0 JRNL AUTH F.FONSECA,E.I.CHUDYK,M.W.VAN DER KAMP,A.CORREIA, JRNL AUTH 2 A.J.MULHOLLAND,J.SPENCER JRNL TITL THE BASIS FOR CARBAPENEM HYDROLYSIS BY CLASS A JRNL TITL 2 BETA-LACTAMASES: A COMBINED INVESTIGATION USING JRNL TITL 3 CRYSTALLOGRAPHY AND SIMULATIONS. JRNL REF J.AM.CHEM.SOC. V. 134 18275 2012 JRNL REFN ISSN 0002-7863 JRNL PMID 23030300 JRNL DOI 10.1021/JA304460J REMARK 2 REMARK 2 RESOLUTION. 1.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.64 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.116 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.114 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.155 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 3418 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 68362 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.111 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.110 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.147 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 3119 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 62938 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2067 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 437 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 2530.7 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 1988.0 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 32 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 24459 REMARK 3 NUMBER OF RESTRAINTS : 31358 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.014 REMARK 3 ANGLE DISTANCES (A) : 0.031 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.029 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.073 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.085 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.055 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.004 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.021 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.098 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: ANISOTROPIC REFINEMENT REDUCED FREE R REMARK 3 (NO CUTOFF) BY 2.07% REMARK 4 REMARK 4 4EV4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-APR-12. REMARK 100 THE DEPOSITION ID IS D_1000072106. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-JUL-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97630 REMARK 200 MONOCHROMATOR : SI(111) DOUBLE CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 68435 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.300 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.7 REMARK 200 DATA REDUNDANCY : 11.90 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 29.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.35 REMARK 200 COMPLETENESS FOR SHELL (%) : 67.1 REMARK 200 DATA REDUNDANCY IN SHELL : 4.60 REMARK 200 R MERGE FOR SHELL (I) : 0.28500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 4EQI REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.83 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NA ACETATE, PEG 3350, PH 7, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.59250 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 39.56350 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 30.97750 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 39.56350 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.59250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 30.97750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 293 REMARK 465 ALA A 294 REMARK 465 LEU A 295 REMARK 465 ARG A 296 REMARK 465 MET A 297 REMARK 465 ALA A 298 REMARK 465 THR A 299 REMARK 465 GLY A 300 REMARK 465 LYS A 301 REMARK 465 SER A 302 REMARK 465 ILE A 303 REMARK 465 GLY A 304 REMARK 465 PHE A 305 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ARG A 204 CD ARG A 204 NE -0.138 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 43 N - CA - CB ANGL. DEV. = -11.8 DEGREES REMARK 500 ARG A 43 CD - NE - CZ ANGL. DEV. = 21.4 DEGREES REMARK 500 ARG A 43 NE - CZ - NH1 ANGL. DEV. = 5.9 DEGREES REMARK 500 ARG A 204 CD - NE - CZ ANGL. DEV. = 45.7 DEGREES REMARK 500 ARG A 204 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 ARG A 204 NE - CZ - NH2 ANGL. DEV. = -4.8 DEGREES REMARK 500 ARG A 222 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 69 -147.24 53.34 REMARK 500 TYR A 97 41.51 -149.17 REMARK 500 ARG A 220 -121.03 -116.68 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MER A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 405 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4EQI RELATED DB: PDB REMARK 900 WT SFC-1 REMARK 900 RELATED ID: 4EUZ RELATED DB: PDB REMARK 900 SFC-1 S70A MUTANT COMPLEXED WITH UNHYDROLYZED MEROPENEM REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE TWO SEQADV RECORDS RELATED TO RESIDUES 255 AND 270 REPRESENT REMARK 999 DISCREPANCIES BETWEEN THE PREVIOUSLY DEPOSITED SEQUENCE (UNP Q6JP75) REMARK 999 AND THE EXPRESSION CLONE, ARISING EITHER FROM PCR ERRORS OR REMARK 999 MISTAKES IN THE ORIGINAL SEQUENCE DBREF 4EV4 A 22 305 UNP Q6JP75 Q6JP75_SERFO 27 309 SEQADV 4EV4 ALA A 166 UNP Q6JP75 GLU 171 ENGINEERED MUTATION SEQADV 4EV4 ALA A 255 UNP Q6JP75 GLY 259 SEE REMARK 999 SEQADV 4EV4 ARG A 270 UNP Q6JP75 LYS 274 SEE REMARK 999 SEQRES 1 A 283 ALA SER GLN PRO PRO GLN VAL THR VAL ASP LYS LEU LYS SEQRES 2 A 283 ARG LEU GLU ASN ASP PHE GLY GLY ARG ILE GLY VAL TYR SEQRES 3 A 283 ALA ILE ASP THR GLY SER ASN LYS THR PHE GLY TYR ARG SEQRES 4 A 283 ALA ASN GLU ARG PHE PRO LEU CYS SER SER PHE LYS GLY SEQRES 5 A 283 PHE LEU ALA ALA ALA VAL LEU SER LYS SER GLN GLN GLN SEQRES 6 A 283 GLU GLY LEU LEU ASN GLN ARG ILE ARG TYR ASP ASN HAR SEQRES 7 A 283 VAL MET GLU PRO HIS SER PRO VAL THR GLU LYS GLN ILE SEQRES 8 A 283 THR THR GLY MET THR VAL ALA GLU LEU SER ALA ALA THR SEQRES 9 A 283 LEU GLN TYR SER ASP ASN GLY ALA ALA ASN LEU LEU LEU SEQRES 10 A 283 GLU LYS LEU ILE GLY GLY PRO GLU GLY MET THR SER PHE SEQRES 11 A 283 MET ARG SER ILE GLY ASP ASN VAL PHE ARG LEU ASP ARG SEQRES 12 A 283 TRP ALA LEU GLU LEU ASN SER ALA ILE PRO GLY ASP ASP SEQRES 13 A 283 ARG ASP THR SER THR PRO LYS ALA VAL ALA GLU SER MET SEQRES 14 A 283 GLN LYS LEU ALA PHE GLY ASN VAL LEU GLY LEU THR GLU SEQRES 15 A 283 ARG HIS GLN LEU MET ASP TRP PHE LYS GLY ASN THR THR SEQRES 16 A 283 GLY GLY ALA ARG ILE ARG ALA SER VAL PRO ALA ASN TRP SEQRES 17 A 283 VAL VAL GLY ASP LYS THR GLY THR CYS GLY VAL TYR GLY SEQRES 18 A 283 THR ALA ASN ASP TYR ALA VAL ILE TRP PRO VAL ALA HIS SEQRES 19 A 283 ALA PRO ILE VAL LEU ALA VAL TYR THR SER LYS PRO ASP SEQRES 20 A 283 ARG ASN SER LYS HIS SER ASP ALA VAL ILE ALA ASP ALA SEQRES 21 A 283 SER ARG ILE VAL LEU GLU SER PHE ASN ILE ASP ALA LEU SEQRES 22 A 283 ARG MET ALA THR GLY LYS SER ILE GLY PHE MODRES 4EV4 HAR A 100 ARG N-OMEGA-HYDROXY-L-ARGININE HET HAR A 100 21 HET MER A 401 26 HET EDO A 402 4 HET EDO A 403 4 HET EDO A 404 4 HET EDO A 405 4 HETNAM HAR N-OMEGA-HYDROXY-L-ARGININE HETNAM MER (4R,5S)-3-{[(3S,5S)-5-(DIMETHYLCARBAMOYL)PYRROLIDIN-3- HETNAM 2 MER YL]SULFANYL}-5-[(2S,3R)-3-HYDROXY-1-OXOBUTAN-2-YL]-4- HETNAM 3 MER METHYL-4,5-D IHYDRO-1H-PYRROLE-2-CARBOXYLIC ACID HETNAM EDO 1,2-ETHANEDIOL HETSYN MER MEROPENEM, BOUND FORM HETSYN EDO ETHYLENE GLYCOL FORMUL 1 HAR C6 H14 N4 O3 FORMUL 2 MER C17 H27 N3 O5 S FORMUL 3 EDO 4(C2 H6 O2) FORMUL 7 HOH *437(H2 O) HELIX 1 1 PRO A 25 GLY A 41 1 17 HELIX 2 2 SER A 71 GLN A 87 1 17 HELIX 3 3 GLY A 89 ASN A 92 5 4 HELIX 4 4 VAL A 108 GLN A 112 5 5 HELIX 5 5 VAL A 119 TYR A 129 1 11 HELIX 6 6 ASP A 131 LEU A 141 1 12 HELIX 7 7 GLY A 143 ILE A 155 1 13 HELIX 8 8 LEU A 167 SER A 171 5 5 HELIX 9 9 THR A 182 GLY A 196 1 15 HELIX 10 10 GLY A 200 GLY A 213 1 14 HELIX 11 11 ARG A 220 VAL A 225 5 6 HELIX 12 12 SER A 275 SER A 289 1 15 SHEET 1 A 5 THR A 56 TYR A 60 0 SHEET 2 A 5 ARG A 43 ASP A 50 -1 N VAL A 46 O TYR A 60 SHEET 3 A 5 ILE A 259 SER A 266 -1 O TYR A 264 N GLY A 45 SHEET 4 A 5 ALA A 244 TRP A 251 -1 N ILE A 250 O ILE A 259 SHEET 5 A 5 VAL A 230 THR A 237 -1 N VAL A 230 O TRP A 251 SHEET 1 B 2 PHE A 66 PRO A 67 0 SHEET 2 B 2 THR A 180 SER A 181 -1 O SER A 181 N PHE A 66 SHEET 1 C 2 ARG A 94 ILE A 95 0 SHEET 2 C 2 MET A 117 THR A 118 -1 O MET A 117 N ILE A 95 SSBOND 1 CYS A 69 CYS A 238 1555 1555 2.10 LINK OG SER A 70 C1 MER A 401 1555 1555 1.35 LINK C ASN A 99 N HAR A 100 1555 1555 1.33 LINK C HAR A 100 N VAL A 101 1555 1555 1.32 SITE 1 AC1 13 CYS A 69 SER A 70 SER A 130 ASN A 132 SITE 2 AC1 13 ASN A 170 LYS A 234 THR A 235 GLY A 236 SITE 3 AC1 13 THR A 237 HOH A 519 HOH A 546 HOH A 586 SITE 4 AC1 13 HOH A 757 SITE 1 AC2 6 PHE A 57 SER A 289 HOH A 516 HOH A 547 SITE 2 AC2 6 HOH A 665 HOH A 846 SITE 1 AC3 6 GLY A 156 ASN A 158 ALA A 185 GLU A 188 SITE 2 AC3 6 HOH A 510 HOH A 768 SITE 1 AC4 4 ARG A 94 THR A 115 GLY A 116 GLU A 121 SITE 1 AC5 7 ARG A 61 ALA A 62 ASN A 63 GLU A 64 SITE 2 AC5 7 HAR A 100 HOH A 525 HOH A 723 CRYST1 59.185 61.955 79.127 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016896 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016141 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012638 0.00000